The 2018 Golden Helix Summer School
‘Rare Genomics : Genomics of Rare Diseases, Rare Cancers &Rare Drug Outcomes’ The 2018 Golden...
One of the key goals of the Genomic Medicine Alliance is to encourage and catalyze multidisciplinary collaborative research between partner institutions and scientists, particularly from emerging countries and to establish collaboration ties among research organizations, clinical entities and regulatory agencies in areas related to genomic medicine.
The National/Ethnic Mutation Databases are mutation depositories, recording extensive information over the described genetic heterogeneity of an ethnic group or population.
More DetailsWe wish to focus on severe drug-induced adverse events, such as Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug-induced liver injury.
More DetailsIn the post-genomic era, we are witnessing significant advances in the functional decipherment of the human genome sequence that have been made possible by new technological developments in the field of genomic medicine.
More DetailsEconomic analysis allows healthcare decision makers to make resource allocation decisions, by performing cost-benefit analysis of the various interventions. Such analyses are important in the area of pharmacogenomics.
More DetailsPublic Health Genomics is the leading international journal focusing on the timely translation of genome-based knowledge and technologies into public health, health policies, and healthcare as a whole. This peer-reviewed journal is a bimonthly forum featuring original papers, reviews, short communications, and policy statements.
View more‘Rare Genomics : Genomics of Rare Diseases, Rare Cancers &Rare Drug Outcomes’ The 2018 Golden...
16, Northumberland Αvenue, Craven House, London WC2N 5AP, United Kingdom
Tel: +44-207-306.91.00,
E-mail: gma {AT} goldenhelix (DOT) org